Evidence map›Paper›PMID 31019309›Full record

ArticleNature protocols2019

Detection and quantification of RNA decay intermediates using XRN1-resistant reporter transcripts.

Franka Voigt, Jennifer V Gerbracht, Volker Boehm, Ivana Horvathova, Jan Eglinger, Jeffrey A Chao, Niels H Gehring

Abstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. SUV3 Helicase and Mitochondrial Homeostasis.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Lighting up single-mRNA translation dynamics in living cells.Current opinion in genetics & development · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Franka VoigtFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Jennifer V GerbrachtInstitute for Genetics, University of Cologne, Cologne, Germany.
Volker BoehmInstitute for Genetics, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-7588-9842
Ivana HorvathovaFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0002-2349-1522
Jan EglingerFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.ORCID http://orcid.org/0000-0001-7234-1435
Jeffrey A ChaoFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland. jeffrey.chao@fmi.ch.ORCID http://orcid.org/0000-0002-5895-9156
Niels H GehringInstitute for Genetics, University of Cologne, Cologne, Germany. ngehring@uni-koeln.de.ORCID http://orcid.org/0000-0001-7792-1164
Friedrich Miescher Institute · CHUniversity of Cologne · DEFriedrich Miescher Institute · CHTH Köln - University of Applied Sciences · DEUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA degradation ensures appropriate levels of mRNA transcripts within cells and eliminates aberrant RNAs. Detailed studies of RNA degradation dynamics have been heretofore infeasible because of the inherent instability of degradation intermediates due to the high processivity of the enzymes involved. To visualize decay intermediates and to characterize the spatiotemporal dynamics of mRNA decay, we have developed a set of methods that apply XRN1-resistant RNA sequences (xrRNAs) to protect mRNA transcripts from 5'-3' exonucleolytic digestion. To our knowledge, this approach is the only method that can detect the directionality of mRNA degradation and that allows tracking of degradation products in unperturbed cells. Here, we provide detailed procedures for xrRNA reporter design, transfection and cell line generation. We explain how to extract xrRNA reporter mRNAs from mammalian cells, as well as their detection and quantification using northern blotting and quantitative PCR. The procedure further focuses on how to detect and quantify intact reporter mRNAs and XRN1-resistant degradation intermediates using single-molecule fluorescence microscopy. It provides detailed instructions for sample preparation and image acquisition using fixed, as well as living, cells. The procedure puts special emphasis on detailed descriptions of high-throughput image analysis pipelines, which are provided along with the article and were designed to perform spot co-localization, detection efficiency normalization and the quality control steps necessary for interpretation of results. The aim of the analysis software published here is to enable nonexpert readers to detect and quantify RNA decay intermediates within 4-6 d after reporter mRNA expression.

Indexed as

ExoribonucleasesMicroscopy, FluorescenceRNA, MessengerRNA StabilitySingle Molecule ImagingExoribonucleasesRNA, Messenger

Identifiers

PMID31019309
OpenAlexW2941355962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.